The Latest Breaking News from BayMedica LLC

BayMedica LLC: Working With Cannabis Multi-State Operators To Make Their Products Better

InMed Pharmaceuticals Inc. (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is taking a leading position in the marketplace.

Benzinga · Jul 5, 2022

InMed Pharmaceuticals Is Commercializing The Development Of Rare Cannabinoids For The Wellness Market

Upon its acquisition of BayMedica LLC last year, InMed Pharmaceuticals Inc. (Nasdaq: INM) made the executive decision to forge a new path alongside its traditional domain in pharmaceutical drug development.

Benzinga · May 17, 2022